NCT00908401

Brief Summary

Hypothesis: Breastmilk has a more powerful analgesic effect than oral sucrose to avoid procedural pain in preterm neonates. The objective is to test this hypothesis in a randomized, controlled study using a standardized and validated pain scale (DAN). The sample size is 21 preterm infants in each two groups. The main end point is a reduction of the risk to have a DAN superior to 1 from 80% with oral sucrose to 40% with breastmilk.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Apr 2009

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 25, 2009

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
Last Updated

May 25, 2009

Status Verified

May 1, 2009

Enrollment Period

3 months

First QC Date

May 22, 2009

Last Update Submit

May 22, 2009

Conditions

Keywords

breastmilkoral sucroseanalgesiapreterm neonatesNeonates

Outcome Measures

Primary Outcomes (1)

  • Decrement from 80 to 40% of frequency of DAN's scale score superior to 1 using breastmilk instead of oral sucrose

    One time during day 3 or 4 then day 7 to 10

Study Arms (2)

sucrose

ACTIVE COMPARATOR

This group will receive oral sucrose for procedural pain

Other: Oral Sucrose

breastmilk

EXPERIMENTAL

this group will receive breastmilk as analgesic product to avoid procedural pain

Other: Breastmilk

Interventions

Breastmilk: 0.2 ml

breastmilk

oral sucrose: 0.2 ml one time 1 minute before the painful procedure with a pacifier

sucrose

Eligibility Criteria

Age3 Days - 10 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm neonates born before 27 and 29+6 weeks GA
  • blood sampling procedure
  • obtention of parental consent

You may not qualify if:

  • congenital malformation
  • intravenous continuous analgesia
  • contraindications to feed
  • high grade intracerebral hemorrhage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Intercommunal de Creteil

Créteil, 94000, France

RECRUITING

Related Publications (3)

  • Schollin J. Analgesic effect of expressed breast milk in procedural pain in neonates. Acta Paediatr. 2004 Apr;93(4):453-5. doi: 10.1080/08035250410027959.

    PMID: 15188969BACKGROUND
  • Carbajal R, Veerapen S, Couderc S, Jugie M, Ville Y. Analgesic effect of breast feeding in term neonates: randomised controlled trial. BMJ. 2003 Jan 4;326(7379):13. doi: 10.1136/bmj.326.7379.13.

    PMID: 12511452BACKGROUND
  • Carbajal R, Paupe A, Hoenn E, Lenclen R, Olivier-Martin M. [APN: evaluation behavioral scale of acute pain in newborn infants]. Arch Pediatr. 1997 Jul;4(7):623-8. doi: 10.1016/s0929-693x(97)83360-x. French.

    PMID: 9295899BACKGROUND

MeSH Terms

Conditions

Pain, ProceduralAgnosia

Interventions

Sucrose

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

DisaccharidesOligosaccharidesPolysaccharidesCarbohydratesSugars

Study Officials

  • Elodie Zana, MD

    Centre Hospitalier Intercommunal Creteil

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 22, 2009

First Posted

May 25, 2009

Study Start

April 1, 2009

Primary Completion

July 1, 2009

Study Completion

July 1, 2009

Last Updated

May 25, 2009

Record last verified: 2009-05

Locations